Search For "sars cov 2"
High doses of favipiravir counter SARS-CoV-2 in hamsters, Hydroxychloroqui
Updated : 5 years, 5 months ago IST
Washington [US], October 10 (ANI): Researchers report that treatment with high doses of favipiravir, an antiviral drug that has been used to treat pandemic influenza in Japan, significantly reduced SARS-CoV-2 levels in the lungs, improved lung pathology, and reduced virus transmission by dir
Read More
Premature relaxation of social-distancing measures undermines gains agains
Updated : 5 years, 5 months ago IST
Washington [US], October 6 (ANI): A study by Massachusetts General Hospital (MGH) has revealed that "premature" relaxation of the statewide physical-distancing measures that have been designed to control the COVID-19 pandemic have frequently resulted in an immediate reversal of public hea
Read More
Study reveals dozens of mammals could be susceptible to SARS-CoV-2
Updated : 5 years, 5 months ago IST
Washington [US], October 5 (ANI): Numerous animals may be vulnerable to SARS-CoV-2, the virus that causes Covid-19, according to a large study modelling how the virus might infect different animals' cells, led by UCL researchers.
Read More
Second sero-survey reveals 1 in 15 individuals aged 10 years or above expo
Updated : 5 years, 5 months ago IST
New Delhi [India], September 29 (ANI): One in 15 individuals aged 10 years or above were estimated to be exposed to SARS-CoV-2 (coronavirus) by August 2020, according to the findings of India Council of Medical Research (ICMR) second sero-survey, said Dr Balram Bhargava, Director General
Read More
Scientists examine neurological consequences of COVID-19
Updated : 5 years, 5 months ago IST
Melbourne [Australia], September 27 (ANI): In a recent study, neuroscientists and clinicians examined the potential link between COVID-19 and increased risk of Parkinson's disease, with an aim to find measures to get ahead of the curve.
Read More
Diminished response by 'killer' T cells responsible for high mortality rat
Updated : 5 years, 5 months ago IST
Washington, [US], September 22 (ANI): Elderly patients face a higher risk of severity and death than younger patients due to COVID- 19, and new research, comparing the immune response among age groups, may help explain the reason why?
Read More
Shorter time from symptom onset to hospitalisation is associated with wors
Updated : 5 years, 5 months ago IST
Washington [US], September 26 (ANI): A shorter time from symptom onset to hospitalisation is associated with a more serious disease and death in patients with COVID-19, suggest the findings of new research.
Read More
Study focuses on neurological consequences of COVID-19
Updated : 5 years, 6 months ago IST
Melbourne [Australia], September 24 (ANI): A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson's disease, and measures to get ahead of the curve.
Read More
Coronavirus strain may have mutated, potentially evolving: Study
Updated : 5 years, 6 months ago IST
Washington [US], September 24 (ANI): Houston researchers have unveiled a study of over 5,000 genetic sequences of coronavirus which reveals the pathogen's virus's continuous accumulation of mutations.
Read More
Researchers find diminished response by 'killer' T cells in elderly COVID-
Updated : 5 years, 6 months ago IST
Washington, [US], September 22 (ANI): Although people of any age can be infected with SARS-CoV-2, the virus that causes COVID-19, elderly patients face a higher risk of severity and death than younger patients. New research, comparing the immune response among age groups, may help explain wh
Read More
Aarti Life Science launches 'Yetocee D3' to fight against COVID-19
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India] September 19 (ANI/PRNewswire): "A daily dose of Yetocee's essential nutrients can ward off disaster," said Vishwa Savla - CEO of Aarti Life Science.
Read More
COVID-19 likely to become a seasonal disease, say scientists
Updated : 5 years, 6 months ago IST
Washington [US], September 19 (ANI): COVID-19, the illness caused by the SARS-CoV-2 virus, will likely become seasonal in countries with temperate climates, but only when herd immunity is attained, suggests a new review published in Frontiers in Public Health.
Read More